Rhea-AI Summary
Equifax Inc. (EFX) Form 144 filing: CEO Mark W. Begor has filed notice to sell up to 48,264 common shares through Fidelity Brokerage on or after 07/28/2025. At the last reported market price, the proposed sale is valued at $11.85 million. The filing lists 123,797,380 shares outstanding, so the planned disposition equals roughly 0.04 % of total shares.
The shares come from two prior equity awards:
- 20,304 shares vested as restricted stock on 05/04/2021 (non-cash compensation).
- 27,960 shares from options granted 02/21/2020 and exercised for cash on 07/28/2025.
No additional financial metrics, earnings data, or company guidance are included in this short-form notice; the document solely satisfies SEC requirements for advance disclosure of certain insider sales.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.6%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.18%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.18%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
FAQ
How many EQUIFAX (EFX) SEC filings are available on StockTitan?
StockTitan tracks 104 SEC filings for EQUIFAX (EFX), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.
When was the most recent SEC filing for EQUIFAX (EFX)?
The most recent SEC filing for EQUIFAX (EFX) was filed on July 28, 2025.